598 related articles for article (PubMed ID: 25582379)
1. γ-PGA-coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release.
Du X; Xiong L; Dai S; Qiao SZ
Adv Healthc Mater; 2015 Apr; 4(5):771-81. PubMed ID: 25582379
[TBL] [Abstract][Full Text] [Related]
2. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
[TBL] [Abstract][Full Text] [Related]
4. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
6. Bio-derived poly(gamma-glutamic acid) nanogels as controlled anticancer drug delivery carriers.
Bae HH; Cho MY; Hong JH; Poo H; Sung MH; Lim YT
J Microbiol Biotechnol; 2012 Dec; 22(12):1782-9. PubMed ID: 23221543
[TBL] [Abstract][Full Text] [Related]
7. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.
Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH
Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578
[TBL] [Abstract][Full Text] [Related]
8. Chitosan oligosaccharide-functionalized nano-prodrug for cascade chemotherapy through oxidative stress amplification.
Cui L; Xu Q; Lou W; Wang Y; Xi X; Chen Y; Sun M; Wang Z; Zhang P; Yang S; Zhang L; Qu L
Int J Biol Macromol; 2024 May; 268(Pt 2):131641. PubMed ID: 38641277
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release.
Cui Y; Dong H; Cai X; Wang D; Li Y
ACS Appl Mater Interfaces; 2012 Jun; 4(6):3177-83. PubMed ID: 22646097
[TBL] [Abstract][Full Text] [Related]
10. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
11. pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release.
Li QL; Xu SH; Zhou H; Wang X; Dong B; Gao H; Tang J; Yang YW
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28656-64. PubMed ID: 26633741
[TBL] [Abstract][Full Text] [Related]
12. Cyclo-γ-polyglutamic acid-coated dual-responsive nanomicelles loaded with doxorubicin for synergistic chemo-photodynamic therapy.
Wang C; Wang B; Zou S; Wang B; Liu G; Zhang F; Wang Q; He Q; Zhang L
Biomater Sci; 2021 Sep; 9(17):5977-5987. PubMed ID: 34338256
[TBL] [Abstract][Full Text] [Related]
13. Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy.
Xu Z; Liu S; Kang Y; Wang M
Nanoscale; 2015 Mar; 7(13):5859-68. PubMed ID: 25757484
[TBL] [Abstract][Full Text] [Related]
14. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
[TBL] [Abstract][Full Text] [Related]
15. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
[TBL] [Abstract][Full Text] [Related]
16. Reduction-responsive drug delivery based on mesoporous silica nanoparticle core with crosslinked poly(acrylic acid) shell.
Li H; Zhang JZ; Tang Q; Du M; Hu J; Yang D
Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3426-31. PubMed ID: 23706230
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional polymer-capped mesoporous silica nanoparticles for pH-responsive targeted drug delivery.
Niedermayer S; Weiss V; Herrmann A; Schmidt A; Datz S; Müller K; Wagner E; Bein T; Bräuchle C
Nanoscale; 2015 May; 7(17):7953-64. PubMed ID: 25865957
[TBL] [Abstract][Full Text] [Related]
18. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
19. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
[TBL] [Abstract][Full Text] [Related]
20. Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.
Dai L; Li J; Zhang B; Liu J; Luo Z; Cai K
Langmuir; 2014 Jul; 30(26):7867-77. PubMed ID: 24933090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
